Андрей Викторович Колосков
Research Subjects
Андрей Викторович Колосков has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Екатерина Владимировна Чернова
North-Western State Medical University Named After I.I. Mechnikov
9 shared publications - E. L. Beliaeva
North-Western State Medical University Named After I.I. Mechnikov
7 shared publications - O. I. Philippova
North-Western State Medical University Named After I.I. Mechnikov
6 shared publications - Valeriy Nikolaevich Marchenko
Pavlov First Saint Petersburg State Medical University
5 shared publications - I. P. Tokareva
North-Western State Medical University Named After I.I. Mechnikov
3 shared publications - A. A. Mangushlo
North-Western State Medical University Named After I.I. Mechnikov
2 shared publications
Latest Publications
- Open Access
- 21 December 2025
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 70 (4) , 521-529
Changes in the “von Willebrand factor—metalloprotease ADAMTS13 system” in patients with ischemic stroke undergoing mechanical thromboextraction depending on the severity of neurological deficiency and the functional outcome
Introduction. The high prevalence of acute cardiovascular diseases and the significant mortality associated with them sustain ongoing interest in the mechanisms of thrombus formation and the factors preceding thrombosis, particularly in the arterial bed. Aim: to assess changes in the quantitative and qualitative characteristics of the metalloprotease ADAMTS13 and von Willebrand factor (vWF) antigen in patients with ischemic stroke (IS) who underwent mechanical thrombectomy, depending on the neurological deficit and functional outcome of the disease. Materials and methods . The study included 52 patients aged 36 –95 years (median age 72 years) who received inpatient treatment for IS, in whom cerebral angiography revealed thrombosis of the intracranial segments of the brachiocephalic arteries followed by mechanical thrombectomy. All patients were tested for vWF antigen, ADAMTS13 activity, ADAMTS13 antigen, and antibodies to ADAMTS13. Venous blood samples for the study were obtained upon hospital admission, 24 hours, and 120 hours after hospitalization. Results. The vWF:Ag values in the group of IS patients with a fatal outcome upon admission exceeded the upper limit of the reference interval but did not statistically differ from the vWF:Ag values in the group of IS patients with a favorable outcome (197.7 % [139.8–255.6] vs. 142.1 % [109.2–195.5], p = 0.071). The vWF:Ag levels at 24 hours and 120 hours in patients with a fatal hospitalization outcome were significantly higher compared to those in recovered patients (236.1 % [201.6–288.6] and 345.6 % [331.7–382.1] vs. 185.2 % [135.1–205.8] and 198.4 % [149.9–256.4]; p = 0.005 and p = 0.001, respectively). In the group of patients with severe IS, the median vWF:Ag level at 120 hours after admission was significantly higher compared to that in the group of patients with mild and moderate IS (291.7 % [199.7–363.2] vs. 187.4 % [130.5–250.9], p = 0.011). No significant differences in the medians of quantitative and qualitative characteristics of the ADAMTS13 metalloprotease were found between groups formed based on either disease outcome or severity of neurological deficit (p > 0.05). Conclusion. Elevated vWF:Ag in patients with an unfavorable outcome of IS indicates endothelial dysfunction and the potential realization of a prothrombotic state. Since the fatal outcome was accompanied by infectious complications, the increase in vWF:Ag should be considered as a reaction of an acute-phase marker. No significant differences in the quantitative and qualitative indicators of ADAMTS13 were found between patient groups with different functional outcomes and neurological deficits.
- 21 December 2025
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 70 (4) , 521-529
Open AccessChanges in the “von Willebrand factor—metalloprotease ADAMTS13 system” in patients with ischemic stroke undergoing mechanical thromboextraction depending on the severity of neurological deficiency and the functional outcome
Introduction. The high prevalence of acute cardiovascular diseases and the significant mortality associated with them sustain ongoing interest in the mechanisms of thrombus formation and the factors preceding thrombosis, particularly in the arterial bed. Aim: to assess changes in the quantitative and qualitative characteristics of the metalloprotease ADAMTS13 and von Willebrand factor (vWF) antigen in patients with ischemic stroke (IS) who underwent mechanical thrombectomy, depending on the neurological deficit and functional outcome of the disease. Materials and methods . The study included 52 patients aged 36 –95 years (median age 72 years) who received inpatient treatment for IS, in whom cerebral angiography revealed thrombosis of the intracranial segments of the brachiocephalic arteries followed by mechanical thrombectomy. All patients were tested for vWF antigen, ADAMTS13 activity, ADAMTS13 antigen, and antibodies to ADAMTS13. Venous blood samples for the study were obtained upon hospital admission, 24 hours, and 120 hours after hospitalization. Results. The vWF:Ag values in the group of IS patients with a fatal outcome upon admission exceeded the upper limit of the reference interval but did not statistically differ from the vWF:Ag values in the group of IS patients with a favorable outcome (197.7 % [139.8–255.6] vs. 142.1 % [109.2–195.5], p = 0.071). The vWF:Ag levels at 24 hours and 120 hours in patients with a fatal hospitalization outcome were significantly higher compared to those in recovered patients (236.1 % [201.6–288.6] and 345.6 % [331.7–382.1] vs. 185.2 % [135.1–205.8] and 198.4 % [149.9–256.4]; p = 0.005 and p = 0.001, respectively). In the group of patients with severe IS, the median vWF:Ag level at 120 hours after admission was significantly higher compared to that in the group of patients with mild and moderate IS (291.7 % [199.7–363.2] vs. 187.4 % [130.5–250.9], p = 0.011). No significant differences in the medians of quantitative and qualitative characteristics of the ADAMTS13 metalloprotease were found between groups formed based on either disease outcome or severity of neurological deficit (p > 0.05). Conclusion. Elevated vWF:Ag in patients with an unfavorable outcome of IS indicates endothelial dysfunction and the potential realization of a prothrombotic state. Since the fatal outcome was accompanied by infectious complications, the increase in vWF:Ag should be considered as a reaction of an acute-phase marker. No significant differences in the quantitative and qualitative indicators of ADAMTS13 were found between patient groups with different functional outcomes and neurological deficits.
- Open Access
- 11 September 2025
- Published by Publishing House ABV Press in Oncohematology
- Vol. 20 (3) , 47-51
Differential diagnostic search for hypereosinophilic syndrome
Idiopathic hypereosinophilic syndrome is characterized by a persistent increase in serum eosinophil counts 1.5 × 109 / L for 4 weeks and the absence of any clinical, laboratory and instrumental data suggesting the etiology of this phenomenon. It is not always possible to confirm the reactive nature of eosinophilia or identify clonal disease. The article presents a clinical case of differential diagnostic search for the cause of hypereosinophilia in a patient.
- 11 September 2025
- Published by Publishing House ABV Press in Oncohematology
- Vol. 20 (3) , 47-51
Open AccessDifferential diagnostic search for hypereosinophilic syndrome
Idiopathic hypereosinophilic syndrome is characterized by a persistent increase in serum eosinophil counts 1.5 × 109 / L for 4 weeks and the absence of any clinical, laboratory and instrumental data suggesting the etiology of this phenomenon. It is not always possible to confirm the reactive nature of eosinophilia or identify clonal disease. The article presents a clinical case of differential diagnostic search for the cause of hypereosinophilia in a patient.
- Open Access
- 22 May 2025
- Published by Publishing House ABV Press in Oncohematology
- Vol. 20 (2) , 75-79
5q– as the only cytogenetic abnormality in myelodysplastic syndrome with blast excess
Cytogenetic studies are required for the diagnosis of myelodysplastic neoplasms (MDS) because the World Health Organization 2022 classification divides MDS into a group with defined genetic abnormalities and MDS that are defined morphologically. Additionally, this paper modifies the terminology to clarify the distinction between MDS with low (5 % in bone marrow) and increased blast cell counts (5–9 % for MDS with blast excess 1 and 10–19 % for MDS with blast excess 2).This article describes the clinical observation of a patient with blast excess MDS and isolated 5q deletion.
- 22 May 2025
- Published by Publishing House ABV Press in Oncohematology
- Vol. 20 (2) , 75-79
Open Access5q– as the only cytogenetic abnormality in myelodysplastic syndrome with blast excess
Cytogenetic studies are required for the diagnosis of myelodysplastic neoplasms (MDS) because the World Health Organization 2022 classification divides MDS into a group with defined genetic abnormalities and MDS that are defined morphologically. Additionally, this paper modifies the terminology to clarify the distinction between MDS with low (5 % in bone marrow) and increased blast cell counts (5–9 % for MDS with blast excess 1 and 10–19 % for MDS with blast excess 2).This article describes the clinical observation of a patient with blast excess MDS and isolated 5q deletion.
- Open Access
- 2 September 2024
- Published by Publishing House ABV Press in Oncohematology
- Vol. 19 (3) , 149-152
Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome
Evaluation of bone marrow cytogenetic abnormalities in myelodysplastic syndrome is of great importance for confirming the clonal disease nature, determining the prognosis and choosing treatment tactics. Cytogenetic abnormalities are detected in 40–70 % of patients with myelodysplastic syndrome, and the variety of these abnormalities reflects the disease characteristics.This article describes the clinical follow-up of a patient with a myelodysplastic neoplasia with blast excess 1 and trisomy of chromosome 14.
- 2 September 2024
- Published by Publishing House ABV Press in Oncohematology
- Vol. 19 (3) , 149-152
Open AccessTrisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome
Evaluation of bone marrow cytogenetic abnormalities in myelodysplastic syndrome is of great importance for confirming the clonal disease nature, determining the prognosis and choosing treatment tactics. Cytogenetic abnormalities are detected in 40–70 % of patients with myelodysplastic syndrome, and the variety of these abnormalities reflects the disease characteristics.This article describes the clinical follow-up of a patient with a myelodysplastic neoplasia with blast excess 1 and trisomy of chromosome 14.
- Open Access
- 18 August 2024
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 69 (2) , 178-188
Characteristics of the hemostatic system “P-selectin — von Willebrand factor — metalloprotease ADAMTS13” during childbirth
Introduction. The physiological task of the blood coagulation system during childbirth is to prevent excessive blood loss.Aim: to evaluate the quantitative and qualitative characteristics in the system P-selectin-von Willebrand factor (vWF)-metallo-protease ADAMTS13 during natural and uncomplicated childbirth in women with a physiological pregnancy.Materials and methods. The study included 40 pregnant women without somatic pathology, with a physiologically progressing pregnancy that ended with physiological birth (general group). Of these, 16 women had their first birth (group 1), 18 had their second birth (group 2) and 6 had their third birth (group 3). Venous blood sampling was performed at three points throughout the study: 1st point — the onset of labor, 2nd point — 2 hours after childbirth and 3rd point — 24 hours after child -birth. The control group consisted of 25 healthy non-pregnant women. The blood samples were examined for: vWF antigen (vWF:Ag), binding ability of vWF to platelet receptor GPIb (vWF:GPIb), binding ability of vWF to collagen type I (vWF:CBAI) and type III (vWF:CBAIII), antigen and activity ADAMTS13 (ADAMTS13:Ag and ADAMTS13:AC), antibodies to ADAMTS13 (ADAMTS13:AB) and P-selectin.Results. The medians of the studied vWF characteristics in the genera l group were statistically significantly higher compared to the control group at all study points, with the exception of the medians of the vWF:GPIb/vWF:Ag ratio, which in the general group were statistically significantly lower at all study points when compared with the control group. The median values of vWF:GPIb and vWF:Ag in women in the second group were statistically significantly higher at all points of the study, compared with similar indicators in both the first and third groups. The median values of ADAMTS13:AC and ADAMTS13:AB in the overall group were statistically significantly higher when compared with the control group at all study points. Median ADAMTS13:Ag and ADAMTS13:AC/ADAMTS13:Ag ratios were statistically significantly lower at all study points. Individual P-selectin values varied widely from 212.1 to 1398 ng/ml, but the medians of this indicator were statistically significantly higher in all study groups and at all study points compared to the control group.Conclusion. The increase in platelet-binding and collagen-binding abilities of vWF suggests that these adhesive properties of the hemostatic protein play an important role in preventing excessive bleeding during labor. Taking into account the decrease in the vWF:GPIb/vWF:Ag ratio compared to the control group, the adhesion of vWF to collagen is more important under these conditions. Despite the fact that ADAMTS13 concentration does not decrease, an actual twofold increase in its activity provides a sufficient antithrombotic effect. The interaction between vWF and ADAMTS13 under conditions of physiological labor does not lead to excessive formation and accumulation of high-affinity antibodies to ADAMTS13.
- 18 August 2024
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 69 (2) , 178-188
Open AccessCharacteristics of the hemostatic system “P-selectin — von Willebrand factor — metalloprotease ADAMTS13” during childbirth
Introduction. The physiological task of the blood coagulation system during childbirth is to prevent excessive blood loss.Aim: to evaluate the quantitative and qualitative characteristics in the system P-selectin-von Willebrand factor (vWF)-metallo-protease ADAMTS13 during natural and uncomplicated childbirth in women with a physiological pregnancy.Materials and methods. The study included 40 pregnant women without somatic pathology, with a physiologically progressing pregnancy that ended with physiological birth (general group). Of these, 16 women had their first birth (group 1), 18 had their second birth (group 2) and 6 had their third birth (group 3). Venous blood sampling was performed at three points throughout the study: 1st point — the onset of labor, 2nd point — 2 hours after childbirth and 3rd point — 24 hours after child -birth. The control group consisted of 25 healthy non-pregnant women. The blood samples were examined for: vWF antigen (vWF:Ag), binding ability of vWF to platelet receptor GPIb (vWF:GPIb), binding ability of vWF to collagen type I (vWF:CBAI) and type III (vWF:CBAIII), antigen and activity ADAMTS13 (ADAMTS13:Ag and ADAMTS13:AC), antibodies to ADAMTS13 (ADAMTS13:AB) and P-selectin.Results. The medians of the studied vWF characteristics in the genera l group were statistically significantly higher compared to the control group at all study points, with the exception of the medians of the vWF:GPIb/vWF:Ag ratio, which in the general group were statistically significantly lower at all study points when compared with the control group. The median values of vWF:GPIb and vWF:Ag in women in the second group were statistically significantly higher at all points of the study, compared with similar indicators in both the first and third groups. The median values of ADAMTS13:AC and ADAMTS13:AB in the overall group were statistically significantly higher when compared with the control group at all study points. Median ADAMTS13:Ag and ADAMTS13:AC/ADAMTS13:Ag ratios were statistically significantly lower at all study points. Individual P-selectin values varied widely from 212.1 to 1398 ng/ml, but the medians of this indicator were statistically significantly higher in all study groups and at all study points compared to the control group.Conclusion. The increase in platelet-binding and collagen-binding abilities of vWF suggests that these adhesive properties of the hemostatic protein play an important role in preventing excessive bleeding during labor. Taking into account the decrease in the vWF:GPIb/vWF:Ag ratio compared to the control group, the adhesion of vWF to collagen is more important under these conditions. Despite the fact that ADAMTS13 concentration does not decrease, an actual twofold increase in its activity provides a sufficient antithrombotic effect. The interaction between vWF and ADAMTS13 under conditions of physiological labor does not lead to excessive formation and accumulation of high-affinity antibodies to ADAMTS13.
- 23 July 2024
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 102 (4) , 309-314
Idiopathic thrombocytopenic purpura
The review presents a modern understanding of the pathophysiology and mechanisms leading to thrombocytopenia, as well as emerging treatment methods for.
- 23 July 2024
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 102 (4) , 309-314
Idiopathic thrombocytopenic purpura
The review presents a modern understanding of the pathophysiology and mechanisms leading to thrombocytopenia, as well as emerging treatment methods for.
- 22 June 2024
- Published by Cifra Ltd - Russian Agency for Digital Standardization (RADS) in Тромбоз, гемостаз и реология
- No. 2,p. 54-59
Changes of P-selectin level in endothelial dysfunction in patients with acute cardiovascular events and sepsis
Введение. Эндотелий сосудистого русла играет роль важнейшей регуляторной системы организма, реализуя свои функции посредством биологически активных молекул, таких как Р-селектин. Дисфункция эндотелия сопровождает значительное количество патологических процессов в организме, в том числе атеросклероз и сепсис. Развитие тромботических осложнений атеросклероза на фоне дисфункции эндотелия и нарушения гемокоагуляции относится к наиболее часто реализуемым патологическим состояниям. Цель исследования: сравнить значения Р-селектина, как одного из маркеров дисфункции эндотелия, у пациентов с сепсисом различной этиологии без тромботических осложнений и у пациентов с тромбозами коронарных и церебральных артерий; изучить динамику значений Р-селектина в период первых 120 ч с момента установления диагноза острой сердечно-сосудистой патологии. Материалы и методы. В наблюдательное сравнительное неконтролируемое исследование включены 93 пациента в возрасте от 36 до 86 (медиана (Ме) = 69) лет: 48 мужчин в возрасте от 36 до 85 (Ме = 61) лет и 45 женщин от 42 до 85 (Ме = 73) лет. Пациенты были разделены на 3 группы в зависимости от характера основной патологии. В группу 1 вошли 45 пациентов, у которых течение основной соматической или хирургической патологии осложнилось сепсисом, но не сопровождалось развитием тромбозов; в группу 2 вошел 21 пациент с острым инфарктом миокарда (ОИМ), сопровождавшимся тромбозом в коронарном бассейне; группу 3 составили 27 больных с острым нарушением мозгового кровообращения (ОНМК) по ишемическому типу на фоне тромбоза крупной церебральной артерии. У всех включенных в исследование пациентов, находившихся на лечении в отделениях реанимации и интенсивной терапии стационара, иммуноферментным методом определяли содержание Р-селектина при поступлении в стационар (в артериальной и венозной крови), а также через 24 и 120 ч от момента госпитализации (в венозной крови). Результаты. Уровень Р-селектина у пациентов группы 1 (1213,0 [1027,0–1342,0] нг/мл) был статистически значимо выше (р < 0,001), чем у пациентов групп 2 (280,7 [245,2–761,0] нг/мл) и 3 (290,4 [248,6–425,1] нг/мл) в артериальной крови, полученной при поступлении в стационар. Заключение. Р-селектин, как маркер гемокоагуляционного и воспалительного звена эндотелиальной дисфункции, при сепсисе без тромботических осложнений демонстрирует более высокие значения в сравнении с острыми сердечно-сосудистыми заболеваниями, сопровождающимися тромбозами в коронарном и церебральных бассейнах, что свидетельствует о преимущественной ассоциации уровня Р-селектина с выраженностью воспалительного ответа и/или системной воспалительной реакции, которая при сепсисе существенно больше. Introduction. Vascular endothelium is the most important regulatory system in the body, functioning through biologically active molecules such as P-selectin. Endothelial dysfunction accompanies a significant number of pathological processes, including atherosclerosis and sepsis. One of the most common pathological conditions is the development of thrombotic complications of atherosclerosis in the context of endothelial dysfunction and impaired hemocoagulation. Aim: to compare P-selectin levels in endothelial dysfunction in patients with somatic pathology complicated by sepsis without thrombotic events and in patients with myocardial infarction and ischemic stroke due to thrombosis in the coronary and cerebral basins during the first 120 hours after diagnosis. Materials and Мethods. The observational, comparative, uncontrolled study included 93 patients aged 36 to 86 (median age (Ме) = 69) years: 48 men aged 36 to 85 (Ме = 61) years and 45 women aged 42 to 85 (Ме = 73) years. Patients were divided into 3 groups: group 1 included 45 patients with sepsis but without thrombotic events; group 2 included 21 patients with acute myocardial...
- 22 June 2024
- Published by Cifra Ltd - Russian Agency for Digital Standardization (RADS) in Тромбоз, гемостаз и реология
- No. 2,p. 54-59
Changes of P-selectin level in endothelial dysfunction in patients with acute cardiovascular events and sepsis
Введение. Эндотелий сосудистого русла играет роль важнейшей регуляторной системы организма, реализуя свои функции посредством биологически активных молекул, таких как Р-селектин. Дисфункция эндотелия сопровождает значительное количество патологических процессов в организме, в том числе атеросклероз и сепсис. Развитие тромботических осложнений атеросклероза на фоне дисфункции эндотелия и нарушения гемокоагуляции относится к наиболее часто реализуемым патологическим состояниям. Цель исследования: сравнить значения Р-селектина, как одного из маркеров дисфункции эндотелия, у пациентов с сепсисом различной этиологии без тромботических осложнений и у пациентов с тромбозами коронарных и церебральных артерий; изучить динамику значений Р-селектина в период первых 120 ч с момента установления диагноза острой сердечно-сосудистой патологии. Материалы и методы. В наблюдательное сравнительное неконтролируемое исследование включены 93 пациента в возрасте от 36 до 86 (медиана (Ме) = 69) лет: 48 мужчин в возрасте от 36 до 85 (Ме = 61) лет и 45 женщин от 42 до 85 (Ме = 73) лет. Пациенты были разделены на 3 группы в зависимости от характера основной патологии. В группу 1 вошли 45 пациентов, у которых течение основной соматической или хирургической патологии осложнилось сепсисом, но не сопровождалось развитием тромбозов; в группу 2 вошел 21 пациент с острым инфарктом миокарда (ОИМ), сопровождавшимся тромбозом в коронарном бассейне; группу 3 составили 27 больных с острым нарушением мозгового кровообращения (ОНМК) по ишемическому типу на фоне тромбоза крупной церебральной артерии. У всех включенных в исследование пациентов, находившихся на лечении в отделениях реанимации и интенсивной терапии стационара, иммуноферментным методом определяли содержание Р-селектина при поступлении в стационар (в артериальной и венозной крови), а также через 24 и 120 ч от момента госпитализации (в венозной крови). Результаты. Уровень Р-селектина у пациентов группы 1 (1213,0 [1027,0–1342,0] нг/мл) был статистически значимо выше (р < 0,001), чем у пациентов групп 2 (280,7 [245,2–761,0] нг/мл) и 3 (290,4 [248,6–425,1] нг/мл) в артериальной крови, полученной при поступлении в стационар. Заключение. Р-селектин, как маркер гемокоагуляционного и воспалительного звена эндотелиальной дисфункции, при сепсисе без тромботических осложнений демонстрирует более высокие значения в сравнении с острыми сердечно-сосудистыми заболеваниями, сопровождающимися тромбозами в коронарном и церебральных бассейнах, что свидетельствует о преимущественной ассоциации уровня Р-селектина с выраженностью воспалительного ответа и/или системной воспалительной реакции, которая при сепсисе существенно больше. Introduction. Vascular endothelium is the most important regulatory system in the body, functioning through biologically active molecules such as P-selectin. Endothelial dysfunction accompanies a significant number of pathological processes, including atherosclerosis and sepsis. One of the most common pathological conditions is the development of thrombotic complications of atherosclerosis in the context of endothelial dysfunction and impaired hemocoagulation. Aim: to compare P-selectin levels in endothelial dysfunction in patients with somatic pathology complicated by sepsis without thrombotic events and in patients with myocardial infarction and ischemic stroke due to thrombosis in the coronary and cerebral basins during the first 120 hours after diagnosis. Materials and Мethods. The observational, comparative, uncontrolled study included 93 patients aged 36 to 86 (median age (Ме) = 69) years: 48 men aged 36 to 85 (Ме = 61) years and 45 women aged 42 to 85 (Ме = 73) years. Patients were divided into 3 groups: group 1 included 45 patients with sepsis but without thrombotic events; group 2 included 21 patients with acute myocardial...
- Open Access
- 15 November 2023
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 68 (3) , 335-343
Comparison of quantitative and qualitative characteristics of the system “P-selectin — platelets — von Willebrand factor — metalloprotease ADAMTS13” in patients with sepsis, idiopathic thrombocytopenic purpura and healthy individuals
Introduction. The blood coagulation system plays a significant role in the pathogenesis of sepsis. Aim: to evaluate changes in the quantitative and qualitative characteristics of von Willebrand factor (vWF), ADAMTS13 metalloprotease and P-selectin in patients with sepsis, comparing them with those in patients with idiopathic thrombocytopenic purpura and in healthy individuals. Materials and methods. The study included 56 patients who received inpatient treatment due to the development of sepsis of various etiologies, 12 patients with idiopathic thrombocytopenic purpura (ITP) and 50 healthy volunteers. In a venous blood sample, the following studies were performed: vWF antigen (vWF:Ag), GPIb-binding ability of vWF (vWF:GPIb), binding ability of vWF to type I collagen (vWF:CBAI), binding ability of vWF to type III collagen I (vWF:CBAIII), P-selectin, ADAMTS13 antigen (ADAMTS13:Ag), ADAMTS13 activity (ADAMTS13:AC) and antibodies to ADAMTS13 (ADAMTS13:AB). Results. The median values of vWF:Ag, vWF:GPIb, vWF:CBAI, and vWF:CBAIII were significantly higher in patients with sepsis compared to healthy individuals and patients with ITP. The median P-selectin in patients with sepsis with thrombocytopenia 1213 ng/mL [1104–1302] was statistically significantly higher than in healthy individuals 74.5 ng/mL [65.0–84.5] (p = 0.0001), and with patients with ITP 389.0 ng/ml [276.2–589.2] (p = 0.0001). Median ADAMTS13:Ag in patients with sepsis with thrombocytopenia < 100×109/l 0.49 U/ml [0.44–0.71] and in patients with ITP 0.67 U/ml [0.62–0.76] were significantly lower compared with healthy individuals 0.97 U/ml [0.84–1.08] (p = 0.001 and p = 0.034, respectively), but the median ADAMTS13:Ag in patients with sepsis with thrombocytopenia was statistically significantly lower than in patients with ITP (p = 0.038). In 19.6 % of cases in patients with sepsis, the ADAMTS13:AB index was higher than 10.0 U/ml (19.6 U/ml [12.1–26.7]), while the median P-selectin indicator in this group of patients was significantly higher when compared with a group of patients with sepsis with an ADAMTS13:AB score of less than 10.00 U/mL (3.04 [2.11–3.94]): 1342 ng/mL[1271–1374] vs. 1130 ng/mL [1087–1271], p = 0.003, respectively. Conclusion. Activation of endothelial cells may underlie the increase in quantitative and qualitative indicators of vWF. Meanwhile, the effect of the adhesive characteristics of vWF (vWF:GPIb, vWF:CBAI and vWF:CBAIII) on the number of platelets in the blood of patients with sepsis was not revealed. Adhesion of vWF to the endothelium through interaction with P-selectin through the platelet GPIb receptor can promote the transition of vWF into a conformational-active state and lead to a decrease in the concentration of ADAMTS13 in the circulation.
- 15 November 2023
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 68 (3) , 335-343
Open AccessComparison of quantitative and qualitative characteristics of the system “P-selectin — platelets — von Willebrand factor — metalloprotease ADAMTS13” in patients with sepsis, idiopathic thrombocytopenic purpura and healthy individuals
Introduction. The blood coagulation system plays a significant role in the pathogenesis of sepsis. Aim: to evaluate changes in the quantitative and qualitative characteristics of von Willebrand factor (vWF), ADAMTS13 metalloprotease and P-selectin in patients with sepsis, comparing them with those in patients with idiopathic thrombocytopenic purpura and in healthy individuals. Materials and methods. The study included 56 patients who received inpatient treatment due to the development of sepsis of various etiologies, 12 patients with idiopathic thrombocytopenic purpura (ITP) and 50 healthy volunteers. In a venous blood sample, the following studies were performed: vWF antigen (vWF:Ag), GPIb-binding ability of vWF (vWF:GPIb), binding ability of vWF to type I collagen (vWF:CBAI), binding ability of vWF to type III collagen I (vWF:CBAIII), P-selectin, ADAMTS13 antigen (ADAMTS13:Ag), ADAMTS13 activity (ADAMTS13:AC) and antibodies to ADAMTS13 (ADAMTS13:AB). Results. The median values of vWF:Ag, vWF:GPIb, vWF:CBAI, and vWF:CBAIII were significantly higher in patients with sepsis compared to healthy individuals and patients with ITP. The median P-selectin in patients with sepsis with thrombocytopenia 1213 ng/mL [1104–1302] was statistically significantly higher than in healthy individuals 74.5 ng/mL [65.0–84.5] (p = 0.0001), and with patients with ITP 389.0 ng/ml [276.2–589.2] (p = 0.0001). Median ADAMTS13:Ag in patients with sepsis with thrombocytopenia < 100×109/l 0.49 U/ml [0.44–0.71] and in patients with ITP 0.67 U/ml [0.62–0.76] were significantly lower compared with healthy individuals 0.97 U/ml [0.84–1.08] (p = 0.001 and p = 0.034, respectively), but the median ADAMTS13:Ag in patients with sepsis with thrombocytopenia was statistically significantly lower than in patients with ITP (p = 0.038). In 19.6 % of cases in patients with sepsis, the ADAMTS13:AB index was higher than 10.0 U/ml (19.6 U/ml [12.1–26.7]), while the median P-selectin indicator in this group of patients was significantly higher when compared with a group of patients with sepsis with an ADAMTS13:AB score of less than 10.00 U/mL (3.04 [2.11–3.94]): 1342 ng/mL[1271–1374] vs. 1130 ng/mL [1087–1271], p = 0.003, respectively. Conclusion. Activation of endothelial cells may underlie the increase in quantitative and qualitative indicators of vWF. Meanwhile, the effect of the adhesive characteristics of vWF (vWF:GPIb, vWF:CBAI and vWF:CBAIII) on the number of platelets in the blood of patients with sepsis was not revealed. Adhesion of vWF to the endothelium through interaction with P-selectin through the platelet GPIb receptor can promote the transition of vWF into a conformational-active state and lead to a decrease in the concentration of ADAMTS13 in the circulation.
- Open Access
- 12 May 2023
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 68 (1) , 62-69-69
The incidence of impaired binding capacity of von Willebrand factor to collagen types I and III in patients with type 1 von Willebrand disease
Introduction. Along with the quantitative characteristics of the von Willebrand factor (vWF), more attention is paid to its qualitative characteristics in patients with von Willebrand disease (vWD). Aim — to evaluate the frequency of vWF binding capacity disorders with type I collagen (vWF:CBAI) and type III collagen (vWF:CBAIII) in patients diagnosed with type 1 vWD and the diagnostic capabilities of these tests. Material and methods. The prospective study included 224 female patients with previously diagnosed vWD type 1. The following tests were performed in the venous blood sample: von Willebrand factor antigen (vWF:Ag), vWF:CBAI, vWF:CBAIII. The control group consisted of 80 healthy female blood donors. Results. In the control group, the values of vWF:CBAI and vWF:CBAIII did not exceed the reference intervals. A decrease in vWF:CBAI was detected in 133 (59.4 %) patients and vWF:CBAIII in 26 (11.6 %) patients. An isolated decrease in vWF:CBAI was detected in 87 (38.8 %) patients . An isolated decrease in vWF:CBAIII was less common — in 6 (2.7 %) patients. Conclusion. The study of vWF:CBAI and vWF:CBAIII appears to be useful as an additional diagnostic test to improve the distinction between healthy individuals and those with VWD.
- 12 May 2023
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 68 (1) , 62-69-69
Open AccessThe incidence of impaired binding capacity of von Willebrand factor to collagen types I and III in patients with type 1 von Willebrand disease
Introduction. Along with the quantitative characteristics of the von Willebrand factor (vWF), more attention is paid to its qualitative characteristics in patients with von Willebrand disease (vWD). Aim — to evaluate the frequency of vWF binding capacity disorders with type I collagen (vWF:CBAI) and type III collagen (vWF:CBAIII) in patients diagnosed with type 1 vWD and the diagnostic capabilities of these tests. Material and methods. The prospective study included 224 female patients with previously diagnosed vWD type 1. The following tests were performed in the venous blood sample: von Willebrand factor antigen (vWF:Ag), vWF:CBAI, vWF:CBAIII. The control group consisted of 80 healthy female blood donors. Results. In the control group, the values of vWF:CBAI and vWF:CBAIII did not exceed the reference intervals. A decrease in vWF:CBAI was detected in 133 (59.4 %) patients and vWF:CBAIII in 26 (11.6 %) patients. An isolated decrease in vWF:CBAI was detected in 87 (38.8 %) patients . An isolated decrease in vWF:CBAIII was less common — in 6 (2.7 %) patients. Conclusion. The study of vWF:CBAI and vWF:CBAIII appears to be useful as an additional diagnostic test to improve the distinction between healthy individuals and those with VWD.
- Open Access
- 22 October 2022
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 67 (3) , 367-376-376
Comparison of quantitative and qualita- tive characteristics of the system von Willebrand factor — metalloprotease ADAMTS13 in patients with acute myocardial in farction and is chemic stroke
Introduction. The hemostasis system plays a key role in the pathogenesis of cardiovascular diseases.Aim — to evaluate changes in quantitative and qualitative characteristics of ADAMTS13 metalloprotease and von Willebrand factor an tigen (vWF:Ag) in patients with acute myocardial in farction (AMI) and is chemic stroke (IS).Patients and methods. The study in cluded 110 patients aged 42–95 years (median age — 64 years), of which: 65 patients with AMI aged 42–81 years (median age — 56 years) who had coronary artery thrombosis during an giography, as well as 45 patients with IS aged 40–95 years (median age — 70 years) with diagnosed cerebral artery thrombosis. All patients were tested for ADAMTS13 an tigen, ADAMTS13 activity, an tibodies to ADAMTS13 and vWF:Ag. Blood samples were obtained during an giography (arterial and venous blood) and 24 and 120 hours after an giography (venous blood).Results. In the group of patients with AMI, an in crease in the values of the vWF:Ag in dicator was revealed, which went beyond the upper limit of the reference in terval. In patients with IS, at the beginning of the study, this in dicator was within the reference in terval and was statistically significantly lower compared to patients with AMI but in creased after 24 hours and peaked at 120 hours. When an alyzing changes in the ADAMTS13:Ag in dicator, it was found that it was statistically significantly higher at all points of the study in the group of patients with AMI, compared with the group of patients with IS, however, the values of this in dicator did not go beyond the reference in terval in patients of both groups. At the same time, the ADAMTS13:AC in dex at all points of the study was statistically significantly higher in patients with IS, compared with the group of patients with AMI, and the ADAMTS13:AB in dex. On the contrary, in the group of AMI patients, this in dicator was statistically significantly higher in all points of the study when compared with that for the group of patients with IS.Conclusion. The study of two pathogenetic models of thrombosis demonstrated the absence of a relationship between the vWF:Ag in dex and the quantitative or qualitative characteristics of the ADAMTS13 metalloprotease. At the same time, an in crease in ADAMTS13:AB in AMI can be considered as the reason for the decrease in ADAMTS13:AC in these patients.
- 22 October 2022
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 67 (3) , 367-376-376
Open AccessComparison of quantitative and qualita- tive characteristics of the system von Willebrand factor — metalloprotease ADAMTS13 in patients with acute myocardial in farction and is chemic stroke
Introduction. The hemostasis system plays a key role in the pathogenesis of cardiovascular diseases.Aim — to evaluate changes in quantitative and qualitative characteristics of ADAMTS13 metalloprotease and von Willebrand factor an tigen (vWF:Ag) in patients with acute myocardial in farction (AMI) and is chemic stroke (IS).Patients and methods. The study in cluded 110 patients aged 42–95 years (median age — 64 years), of which: 65 patients with AMI aged 42–81 years (median age — 56 years) who had coronary artery thrombosis during an giography, as well as 45 patients with IS aged 40–95 years (median age — 70 years) with diagnosed cerebral artery thrombosis. All patients were tested for ADAMTS13 an tigen, ADAMTS13 activity, an tibodies to ADAMTS13 and vWF:Ag. Blood samples were obtained during an giography (arterial and venous blood) and 24 and 120 hours after an giography (venous blood).Results. In the group of patients with AMI, an in crease in the values of the vWF:Ag in dicator was revealed, which went beyond the upper limit of the reference in terval. In patients with IS, at the beginning of the study, this in dicator was within the reference in terval and was statistically significantly lower compared to patients with AMI but in creased after 24 hours and peaked at 120 hours. When an alyzing changes in the ADAMTS13:Ag in dicator, it was found that it was statistically significantly higher at all points of the study in the group of patients with AMI, compared with the group of patients with IS, however, the values of this in dicator did not go beyond the reference in terval in patients of both groups. At the same time, the ADAMTS13:AC in dex at all points of the study was statistically significantly higher in patients with IS, compared with the group of patients with AMI, and the ADAMTS13:AB in dex. On the contrary, in the group of AMI patients, this in dicator was statistically significantly higher in all points of the study when compared with that for the group of patients with IS.Conclusion. The study of two pathogenetic models of thrombosis demonstrated the absence of a relationship between the vWF:Ag in dex and the quantitative or qualitative characteristics of the ADAMTS13 metalloprotease. At the same time, an in crease in ADAMTS13:AB in AMI can be considered as the reason for the decrease in ADAMTS13:AC in these patients.